46.000
−0,97%
2026-10-19
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -2.3% | -1.7% | 0 / 3 | -0.6% | -3.29 pp | -0.13 pp | +16.6% | 0.15 | 14.98 | 472 | −0,6% | 89,2 | −1,3% | 14.98 | 16.34 | −8,3% |
| Pts | 0 | 0 | 0 | 0 | 0 | 4 | 4 | 12 | 8 | |||||||
Valuation annotation:Price: 46.000 (close price on 2026-10-19)EPS (TTM): 3.070
Financial charts
1.Revenue & growth
VND bn472Q2/26
1.Revenue & growth
VND bn472Q2/26
2.Profit & growth
VND bn89,2Q2/26
3.Profit mix (Penman)
VND bn347Q2/26
4.Margins & cost structure
%45.1%Q2/26
5.Returns & cash cycle
% · days19.1%Q2/26
6.Earnings quality & cash
VND bn431Q2/26
7.Asset structure
VND bn2.810Q2/26
8.Funding & debt health
VND bn · times2.810Q2/26
9.Revenue backlog
VND bn12,5Q2/26
10.Valuation
times · %15,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %943Q2/26
Adjusted EPS growth, latest quarter
-2.3%
Average adjusted EPS growth, 3 quarters
-1.7%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
1.0%
Source: vnstockData through Q2/26